User menu

Long-term survival after pancreatic resection for renal cell carcinoma metastasis

Bibliographic reference Schwarz, L ; Sauvanet, A ; Regenet, N ; Mabrut, J Y ; Gigot, Jean-François ; et. al. Long-term survival after pancreatic resection for renal cell carcinoma metastasis. In: Annals of Surgical Oncology, Vol. 21, no. 12, p. 4007-4013 (2014)
Permanent URL http://hdl.handle.net/2078.1/151758
  1. Cancer I-IAfRo. GLOBOCAN 2012: estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. 2012.
  2. Cindolo Luca, Patard Jean-Jacques, Chiodini Paolo, Schips Luigi, Ficarra Vincenzo, Tostain Jacques, de La Taille Alexandre, Altieri Vincenzo, Lobel Bernard, Zigeuner Richard E., Artibani Walter, Guillé François, Abbou Claude C., Salzano Luigi, Gallo Ciro, Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy : A Multicenter European Study, 10.1002/cncr.21331
  3. KATTAN MICHAEL W., REUTER VICTOR, MOTZER ROBERT J., KATZ JARED, RUSSO PAUL, A POSTOPERATIVE PROGNOSTIC NOMOGRAM FOR RENAL CELL CARCINOMA, 10.1016/s0022-5347(05)66077-6
  4. Leibovich Bradley C., Blute Michael L., Cheville John C., Lohse Christine M., Frank Igor, Kwon Eugene D., Weaver Amy L., Parker Alexander S., Zincke Horst, Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma : A stratification tool for prospective clinical trials, 10.1002/cncr.11234
  5. Brookman-May SD, May M, Shariat SF, et al. Time to recurrence is a significant predictor of cancer-specific survival after recurrence in patients with recurrent renal cell carcinoma–results from a comprehensive multi-centre database (CORONA/SATURN-Project). BJU Int. 2013;112(7):909–16.
  6. McDermott David F., Regan Meredith M., Clark Joseph I., Flaherty Lawrence E., Weiss Geoffery R., Logan Theodore F., Kirkwood John M., Gordon Michael S., Sosman Jeffrey A., Ernstoff Marc S., Tretter Christopher P.G., Urba Walter J., Smith John W., Margolin Kim A., Mier James W., Gollob Jared A., Dutcher Janice P., Atkins Michael B., Randomized Phase III Trial of High-Dose Interleukin-2 Versus Subcutaneous Interleukin-2 and Interferon in Patients With Metastatic Renal Cell Carcinoma, 10.1200/jco.2005.03.206
  7. Negrier Sylvie, Escudier Bernard, Lasset Christine, Douillard Jean-Yves, Savary Jacqueline, Chevreau Christine, Ravaud Alain, Mercatello Alain, Peny Jean, Mousseau Mireille, Philip Thierry, Tursz Thomas, Recombinant Human Interleukin-2, Recombinant Human Interferon Alfa-2a, or Both in Metastatic Renal-Cell Carcinoma, 10.1056/nejm199804303381805
  8. Escudier Bernard, Bellmunt Joaquim, Négrier Sylvie, Bajetta Emilio, Melichar Bohuslav, Bracarda Sergio, Ravaud Alain, Golding Sophie, Jethwa Sangeeta, Sneller Vesna, Phase III Trial of Bevacizumab Plus Interferon Alfa-2a in Patients With Metastatic Renal Cell Carcinoma (AVOREN): Final Analysis of Overall Survival, 10.1200/jco.2009.26.7849
  9. Rini Brian I., Halabi Susan, Rosenberg Jonathan E., Stadler Walter M., Vaena Daniel A., Ou San-San, Archer Laura, Atkins James N., Picus Joel, Czaykowski Piotr, Dutcher Janice, Small Eric J., Bevacizumab Plus Interferon Alfa Compared With Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: CALGB 90206, 10.1200/jco.2008.16.9847
  10. Kavolius JP, Mastorakos DP, Pavlovich C, Russo P, Burt ME, Brady MS. Resection of metastatic renal cell carcinoma. J Clin Oncol. 1998;16(6):2261–6.
  11. Kierney Philip C., van Heerden Jon A., Segura Joseph W., Weaver Amy L., Surgeon's role in the management of solitary renal cell carcinoma metastases occurring subsequent to initial curative nephrectomy: An institutional review, 10.1007/bf02303572
  12. Sohn T, Renal cell carcinoma metastatic to the pancreas: results of surgical management, 10.1016/s1091-255x(01)80060-3
  13. Tanis P. J., van der Gaag N. A., Busch O. R. C., van Gulik T. M., Gouma D. J., Systematic review of pancreatic surgery for metastatic renal cell carcinoma, 10.1002/bjs.6606
  14. Bassi C., Butturini G., Falconi M., Sargenti M., Mantovani W., Pederzoli P., High recurrence rate after atypical resection for pancreatic metastases from renal cell carcinoma, 10.1002/bjs.4072
  15. Sellner Franz, Tykalsky Natascha, De Santis Maria, Pont Jörg, Klimpfinger M., Solitary and Multiple Isolated Metastases of Clear Cell Renal Carcinoma to the Pancreas: An Indication for Pancreatic Surgery, 10.1245/aso.2006.03.064
  16. Thompson Lester D. R., Heffess Clara S., Renal cell carcinoma to the pancreas in surgical pathology material : A clinicopathologic study of 21 cases with a review of the literature, 10.1002/1097-0142(20000901)89:5<1076::aid-cncr17>3.0.co;2-m
  17. Demirjian Aram N., Vollmer Charles M., McDermott David F., Mullen John T., Atkins Michael B., Callery Mark P., Refining indications for contemporary surgical treatment of renal cell carcinoma metastatic to the pancreas, 10.1111/j.1477-2574.2009.00027.x
  18. Motzer RJ, Mazumdar M, Bacik J, Berg W, Amsterdam A, Ferrara J. Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. J Clin Oncol. 1999;17(8):2530–40.
  19. Miller K., Renal Cell Carcinoma, 10.1159/000030411
  20. Zerbi Alessandro, Ortolano Enrico, Balzano Gianpaolo, Borri Anna, Beneduce Aldo Alberto, Di Carlo Valerio, Pancreatic Metastasis From Renal Cell Carcinoma: Which Patients Benefit From Surgical Resection?, 10.1245/s10434-007-9782-0
  21. Z'graggen Kaspar, Metastases to the Pancreas and Their Surgical Extirpation, 10.1001/archsurg.133.4.413
  22. Escudier Bernard, Pluzanska Anna, Koralewski Piotr, Ravaud Alain, Bracarda Sergio, Szczylik Cezary, Chevreau Christine, Filipek Marek, Melichar Bohuslav, Bajetta Emilio, Gorbunova Vera, Bay Jacques-Olivier, Bodrogi Istvan, Jagiello-Gruszfeld Agnieszka, Moore Nicola, Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial, 10.1016/s0140-6736(07)61904-7
  23. Escudier Bernard, Szczylik Cezary, Hutson Thomas E., Demkow Tomasz, Staehler Michael, Rolland Frédéric, Negrier Sylvie, Laferriere Nicole, Scheuring Urban J., Cella David, Shah Sonalee, Bukowski Ronald M., Randomized Phase II Trial of First-Line Treatment With Sorafenib Versus Interferon Alfa-2a in Patients With Metastatic Renal Cell Carcinoma, 10.1200/jco.2008.19.3342
  24. Motzer Robert J., Hutson Thomas E., Tomczak Piotr, Michaelson M. Dror, Bukowski Ronald M., Oudard Stéphane, Negrier Sylvie, Szczylik Cezary, Pili Roberto, Bjarnason Georg A., Garcia-del-Muro Xavier, Sosman Jeffrey A., Solska Ewa, Wilding George, Thompson John A., Kim Sindy T., Chen Isan, Huang Xin, Figlin Robert A., Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma, 10.1200/jco.2008.20.1293
  25. Hudes Gary, Carducci Michael, Tomczak Piotr, Dutcher Janice, Figlin Robert, Kapoor Anil, Staroslawska Elzbieta, Sosman Jeffrey, McDermott David, Bodrogi István, Kovacevic Zoran, Lesovoy Vladimir, Schmidt-Wolf Ingo G.H., Barbarash Olga, Gokmen Erhan, O'Toole Timothy, Lustgarten Stephanie, Moore Laurence, Motzer Robert J., Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma, 10.1056/nejmoa066838
  26. MOTZER ROBERT J., RUSSO PAUL, SYSTEMIC THERAPY FOR RENAL CELL CARCINOMA, 10.1016/s0022-5347(05)67889-5
  27. Rini Brian I, Campbell Steven C, Escudier Bernard, Renal cell carcinoma, 10.1016/s0140-6736(09)60229-4
  28. Molina A.M., Lin X., Korytowsky B., Matczak E., Lechuga M.J., Wiltshire R., Motzer R.J., Sunitinib objective response in metastatic renal cell carcinoma: Analysis of 1059 patients treated on clinical trials, 10.1016/j.ejca.2013.08.021
  29. Kanzaki Ryu, Higashiyama Masahiko, Fujiwara Ayako, Tokunaga Toshiteru, Maeda Jun, Okami Jiro, Nishimura Kazuo, Kodama Ken, Long-term results of surgical resection for pulmonary metastasis from renal cell carcinoma: a 25-year single-institution experience, 10.1016/j.ejcts.2010.05.021
  30. van der Poel Henk G., Roukema Jan A., Horenblas Simon, van Geel Albert N., Debruyne Frans M.J., Metastasectomy in Renal Cell Carcinoma: A Multicenter Retrospective Analysis, 10.1159/000019849
  31. Kwak Cheol, Park Yong Hyun, Jeong Chang Wook, Lee Sang Eun, Ku Ja Hyeon, Metastasectomy without Systemic Therapy in Metastatic Renal Cell Carcinoma: Comparison with Conservative Treatment, 10.1159/000106329
  32. Kyoda Yuki, Kobayashi Ko, Hirobe Megumi, Shindo Tetsuya, Fukuta Fumimasa, Hashimoto Kohei, Tanaka Toshiaki, Tonooka Akiko, Kitamura Hiroshi, Takahashi Satoshi, Masumori Naoya, Hasegawa Tadashi, Tsukamoto Taiji, Evaluation of long-term outcome for patients with renal cell carcinoma after surgery: analysis of cancer deaths occurring more than 10 years after initial treatment, 10.1007/s10147-013-0533-x
  33. Vogl U M, Zehetgruber H, Dominkus M, Hejna M, Zielinski C C, Haitel A, Schmidinger M, Prognostic factors in metastatic renal cell carcinoma: metastasectomy as independent prognostic variable, 10.1038/sj.bjc.6603327
  34. Motzer Robert J., Hutson Thomas E., Tomczak Piotr, Michaelson M. Dror, Bukowski Ronald M., Rixe Olivier, Oudard Stéphane, Negrier Sylvie, Szczylik Cezary, Kim Sindy T., Chen Isan, Bycott Paul W., Baum Charles M., Figlin Robert A., Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma, 10.1056/nejmoa065044
  35. FAURE JEAN-PIERRE, TUECH JEAN-JACQUES, RICHER JEAN-PIERRE, PESSAUX PATRICK, ARNAUD JEAN-PIERRE, CARRETIER MICHEL, PANCREATIC METASTASIS OF RENAL CELL CARCINOMA: PRESENTATION, TREATMENT AND SURVIVAL, 10.1097/00005392-200101000-00005
  36. Reddy Sushanth, Edil Barish H., Cameron John L., Pawlik Timothy M., Herman Joseph M., Gilson Marta M., Campbell Kurtis A., Schulick Richard D., Ahuja Nita, Wolfgang Christopher L., Pancreatic Resection of Isolated Metastases from Nonpancreatic Primary Cancers, 10.1245/s10434-008-0140-7
  37. Wente Moritz N, Kleeff J??rg, Esposito Irene, Hartel Mark, M??ller Michael W, Fr??hlich Boris E, B??chler Markus W, Friess Helmut, Renal Cancer Cell Metastasis Into the Pancreas : A Single-Center Experience and Overview of the Literature, 10.1097/01.mpa.0000153337.58105.47
  38. Law Calvin H. L., Wei Alice C., Hanna Sherif S., Al-Zahrani Mohamed, Taylor Bryce R., Greig Paul D., Langer Bernard, Gallinger Steven, Pancreatic Resection for Metastatic Renal Cell Carcinoma: Presentation, Treatment, and Outcome, 10.1245/aso.2003.02.003
  39. Konstantinidis Ioannis T., Dursun Abdulmetin, Zheng Hui, Wargo Jennifer A., Thayer Sarah P., Fernandez-del Castillo Carlos, Warshaw Andrew L., Ferrone Cristina R., Metastatic Tumors in the Pancreas in the Modern Era, 10.1016/j.jamcollsurg.2010.08.017
  40. Masetti Michele, Zanini Nicola, Martuzzi Federica, Fabbri Carlo, Mastrangelo Laura, Landolfo Giovanni, Fornelli Adele, Burzi Marcellino, Vezzelli Elena, Jovine Elio, Analysis of Prognostic Factors in Metastatic Tumors of the Pancreas : A Single-Center Experience and Review of the Literature, 10.1097/mpa.0b013e3181bae9b3
  41. Eggener Scott E., Yossepowitch Ofer, Pettus Joseph A., Snyder Mark E., Motzer Robert J., Russo Paul, Renal Cell Carcinoma Recurrence After Nephrectomy for Localized Disease: Predicting Survival From Time of Recurrence, 10.1200/jco.2005.04.8280
  42. Cameron John L., Riall Taylor S., Coleman JoAnn, Belcher Kenneth A., One Thousand Consecutive Pancreaticoduodenectomies : , 10.1097/01.sla.0000217673.04165.ea
  43. Sciarra Alessandro, Cattarino Susanna, Salciccia Stefano, Alfarone Andrea, Gentilucci Alessandro, Parente Ulderico, Mariotti Gianna, Innocenzi Michele, Gentile Vincenzo, The emerging role of targeted therapy in renal cell carcinoma (RCC): Is it time for a neoadjuvant or an adjuvant approach?, 10.1016/j.critrevonc.2011.02.003